High prevalence of targetable drivers but poor outcomes in lung adenocarcinoma: a real-world cohort from the French West Indies
Régine Marlin(Centre Hospitalier Universitaire de Martinique), Moustapha Agossou(Centre Hospitalier Universitaire de Martinique), Stefanos Bougas(Centre Hospitalier Universitaire de Martinique), Jean-Marc Rakotonarivo(Centre Hospitalier Universitaire de Martinique), Moustapha Dramé(Centre Hospitalier Universitaire de Martinique), Émeline Colomba(Université Paris-Saclay), Karim Fard(Centre Hospitalier Universitaire de Martinique), Adel Zouzou(Centre Hospitalier Universitaire de Martinique), Sabrina Pennont(Centre Hospitalier Universitaire de Saint-Pierre), Marlyne Moranton(Centre Hospitalier Universitaire de Martinique), M Aldea(Université Paris-Saclay), Heriniaina Randriamiarisoa(Centre Hospitalier Universitaire de Saint-Pierre), Soizic Masson(Centre Hospitalier Universitaire de Martinique), Jacques Jougon(Centre Hospitalier Universitaire de Saint-Pierre), N. Boukadoum(Centre Hospitalier Universitaire de Martinique)
Cited by 0
Related Papers
Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohort
|Nature Cancer|2020|119
Obese Patients With Long COVID-19 Display Abnormal Hyperventilatory Response and Impaired Gas Exchange at Peak Exercise
|Future Cardiology|2022|25
Incidence of Lung Adenocarcinoma Biomarker in a Caribbean and African Caribbean Population
|Journal of Thoracic Oncology|2016|14
Phenotypic Profiles Among 72 Caucasian and Afro-Caribbean Patients with Antisynthetase Syndrome Involving Anti-PL7 or Anti-PL12 Autoantibodies
|European Journal of Internal Medicine|2023|12